Exelixis, Inc. (EXEL) Stock Plummets Following Disappointing Interim Results for COSMIC-312 Clinical Trial
ST Staff
June 28, 2021
Exelixis, Inc. (EXEL) stock prices were down by a significant 19.46% as of the market opening on June 28th, 2021, bringing the price down to